Straumann Holding AG: Dental Platform Leader at a Demanding Price
Straumann is the global leader in specialty dentistry, a Swiss platform that grew from a premium implant maker into a multi-brand, multi-price-point group spanning implants, digital workflows, biomaterials, prosthetics, and clear aligners, with CHF 2.61 billion of 2025 revenue and about 35% of a CHF 6.0 billion implant market. The franchise quality is genuine (ROCE 30.6%, equity ratio 57.6%, a decade of share gains), but gross margin has drifted from 76.2% to 68.6% and free-cash-flow margin from 21.8% to 11.1% as value-tier and digital mix grew, and the stock trades near 35.8x core earnings on a 1.7% free-cash-flow yield. Rating Hold: a high-quality compounder with a long runway, but the price already discounts much of the next margin and ecosystem leg, leaving little margin of safety.